EUVIMEDEUVIMED entdecken
Crossref

Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries

Pauline P Huynh iD, C Kwang Sung, Nancy Jiang

The Laryngoscope · 2025

DOI: 10.1002/lary.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Pauline P Huynh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head & Neck Surgery, Kaiser Permanente Oakland Medical Center, Oakland, California, USA. Hauptthemen laut MEDLINE: Laryngoplasty, Medicare, Vocal Cords, Vocal Cord Paralysis. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective(s) To characterize utilization patterns of laryngeal injection procedures (augmentation and therapeutic) and medialization thyroplasty from 2012 to 2022, with particular attention to practice setting, bilateral procedures, and impact of the 2017 Healthcare Common Procedure Coding System (HCPCS) update.

Methods

The Centers for Medicare and Medicaid Services (CMS) Physician/Supplier Procedure Summary (PSPS) Master dataset from 2012 to 2022 was utilized in this analysis. HCPCS codes specific for vocal fold injections (e.g., 31513, 31570, 31571, 31573, 31574) and thyroplasty procedures (e.g., 31588, 31591) were evaluated. The number of procedures performed, place of service, and specialty were recorded.

Results

Total laryngeal procedures increased by 44.7% from 2012 through 2022, including a 52.3% increase in injections and an 11.9% decrease in thyroplasty. Laryngeal injection procedures increased across all practice settings, with a notable trend toward office‐based procedures (20% to 28%). In contrast, the proportion of laryngeal injection procedures in the hospital and ambulatory surgical center settings decreased from a height of 70%–60% and 17%–13%, respectively. Bilateral procedures increased by 165%, including a 121% increase in bilateral injection augmentation (code 31574).

Conclusion

Between 2012 and 2022, total laryngeal procedures increased across all practice settings, with a trend toward more injection laryngoplasty, particularly in the office setting. The growth of bilateral procedures, particularly injection augmentation, suggests a growing demand to treat bilateral presbylarynx. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaryngoplastyMedicareVocal CordsVocal Cord ParalysisHumansUnited StatesInjectionsPractice Patterns, Physicians'

Stichwörter der Autor:innen

HCPSC codesinjection augmentationinjection laryngoplastymedicare coding patternsthyroplastyutilization trendsvocal fold injection

Autor:innen und Institutionen

  • Department of Head & Neck Surgery, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.
  • Division of Laryngology, Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Pauline P Huynh

Zitieren

APA

Huynh, P. P., Sung, C. K., & Jiang, N. (2025). Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries. The Laryngoscope. https://doi.org/10.1002/lary.70226

Vancouver

Huynh PP, Sung CK, Jiang N. Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries. The Laryngoscope. 2025. doi:10.1002/lary.70226

BibTeX
@article{Huynh2025,
  author = {Huynh, Pauline P and Sung, C Kwang and Jiang, Nancy},
  title = {Vocal Fold Injection and Thyroplasty Trends From 2012 to 2022 Among Medicare Beneficiaries},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.70226}
}
Kostenlos starten →